Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Mirum Pharmaceuticals (MIRM) Interest Coverage Ratio (2020 - 2025)

Mirum Pharmaceuticals has reported Interest Coverage Ratio over the past 6 years, most recently at 1.27 for Q4 2025.

  • Quarterly results put Interest Coverage Ratio at 1.27 for Q4 2025, up 81.24% from a year ago — trailing twelve months through Dec 2025 was 1.54 (up 74.87% YoY), and the annual figure for FY2025 was 1.54, up 74.87%.
  • Interest Coverage Ratio for Q4 2025 was 1.27 at Mirum Pharmaceuticals, down from 0.72 in the prior quarter.
  • Over the last five years, Interest Coverage Ratio for MIRM hit a ceiling of 0.72 in Q3 2025 and a floor of 14.08 in Q1 2021.
  • Median Interest Coverage Ratio over the past 5 years was 7.22 (2023), compared with a mean of 6.71.
  • Biggest five-year swings in Interest Coverage Ratio: dropped 16.7% in 2023 and later soared 120.41% in 2025.
  • Mirum Pharmaceuticals' Interest Coverage Ratio stood at 12.1 in 2021, then soared by 35.24% to 7.84 in 2022, then fell by 16.7% to 9.15 in 2023, then increased by 26.0% to 6.77 in 2024, then skyrocketed by 81.24% to 1.27 in 2025.
  • The last three reported values for Interest Coverage Ratio were 1.27 (Q4 2025), 0.72 (Q3 2025), and 1.39 (Q2 2025) per Business Quant data.